Supplementary Figure S4 from A First-in-Class mAb (BI-1607) Targeting FcγRIIB: Preclinical Data and First-in-Human Studies in Patients with HER2-Positive Advanced Solid Tumors
Year: 2025
Type: supplementary-materials
Abstract: Figure S4. Pharmacokinetic (PK) and receptor occupancy (RO) modeling results
Authors: Javier Cortés, Araceli Priego, Elena Garralda, Katerin Rojas, Simon R. Lord, Thorsten O. Goetze, Sherko Kuemmel, Simon J. Crabb, Zinnia P. Parra-Guillen, Marie Borggren, Ingrid Karlsson, Danijela Lindahl, Linda Mårtensson, Robert Oldham, Anna Ropenga, Ingrid Teige, Johan Wallin, Björn Frendeus, Andres McAllister
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: gold
OpenAlex ID: W4416844752